Mixed Topics
Conference Coverage
Most women can conceive after breast cancer treatment
In a modern cohort of patients under 40 without metastatic disease, financial status and egg or embryo freezing — but not chemotherapy — affected...
News
Urine Tests Could Be ‘Enormous Step’ in Diagnosing Cancer
Cancer biomarkers in urine are not nearly as widely studied as those in the blood, but a new wave of urine tests suggests research is gaining pace...
News
Hypofractionated Radiotherapy Limits Toxic Effects in Cervical Cancer
Researchers analyze outcomes from patients undergoing hypofractionated IMRT for cervical cancer after radical hysterectomy and pelvic lymph node...
Conference Coverage
New mRNA Vaccines in Development for Cancer and Infections
Different forms and designations of mRNA vaccines are used, depending on the application and desired effect.
News
Can a Risk Score Predict Kidney Injury After Cisplatin?
Researchers have developed a risk algorithm to predict acute kidney injury after cisplatin administration and tested it using data from six US...
News
Do Patients Benefit from Cancer Trial Participation?
Researchers conduct a meta-analysis comprising 141 comparisons of an investigational drug and a control treatment, which include immunotherapies...
News
The Long, Controversial Search for a ‘Cancer Microbiome’
Research raised as many questions as answers about what we do and don’t know about microbiota and cancer.
Article
Recurrent Soft Tissue Rosai Dorfman Disease of Right Medial Thigh Lipoma With Lymph Node Involvement
Best addressed with multidisciplinary management, Rosai Dorfman disease typically occurs in older adults and is often associated with soft tissue...
Article
3D Printing for the Development of Palatal Defect Prosthetics
Can computed tomography be used to construct 3D printed palatal obturator prosthetics for defects in patients treated for head and neck cancers?...
News
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...
